pharmaceutical investing Cytokinetics and Astellas Provide Updates Regarding Collaborative Skeletal Muscle Program
pharmaceutical investing Approval of Linzess Tablets 0.25 mg in Japan for Additional Indication of Chronic Constipation
Goldgroup Enters Into Agreement To Sell Subsidiary Minera Apolo, S.A. de C.V., Disposing of Pinos Project
